Leavitt Partners Welcomes Mark Hendrickson to the Firm

Salt Lake City, July 17, 2019 –Today, Leavitt Partners welcomes Mark Hendrickson as a Senior Director based in our Washington, D.C. office. Mark comes to Leavitt Partners with more than 20 years of experience in health care policy and government affairs roles in Washington, D.C. advocacy.

Mark most recently served as Senior Director of Sciences and Regulatory Affairs at the Association for Accessible Medicines (AAM).  In this role, he served as a policy expert and project manager coordinating member working groups and activities with key government agencies, including the Food and Drug Administration (FDA). Mark has extensive experience in preparing reports for, drafting regulatory comments to, and testifying before the FDA. He also served as an industry negotiator for user fee agreements with the FDA, including the Generic Drug user fee agreement (GDUFA II) and the Biosimilar User Fee Agreement (BsUFA II). Additionally, Mark recently managed several industry working groups focused on pharmaceutical supply chain security and DSCSA implementation.

Vince Ventimiglia, chairman, Leavitt Partners Board of Managers noted, “Mark’s federal policy work over that last two decades demonstrates the highest degree of integrity, expertise, and collaboration among the full range of health care stakeholders on a variety of FDA-related initiatives. We look forward to his leading several new initiatives and working on federal affairs projects as we improve lives by advancing value-based health care.”

About Leavitt Partners:

Leavitt Partners is a health care intelligence business. The firm helps clients successfully navigate the evolving role of value in health care by informing, advising, and convening industry leaders on value market analytics, alternative payment models, federal strategies, insurance market insights, and alliances. Through its family of businesses, the firm provides investment support, data and analytics, member-based alliances, and direct services to clients to support decision-making strategies in the value economy. For more information please visit